Oncosil Medical Ltd
ASX:OSL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abans Holdings Ltd
NSE:AHL
|
IN |
|
I
|
Inin Group AS
OSE:ININ
|
NO |
|
Halwani Brothers Co SJSC
SAU:6001
|
SA |
|
Saizeriya Co Ltd
TSE:7581
|
JP |
|
W
|
WMG Holdings Bhd
KLSE:WMG
|
MY |
|
Friwo AG
XETRA:CEA
|
DE |
|
Manali Petrochemicals Ltd
NSE:MANALIPETC
|
IN |
|
Global Dining Holdings Ltd
HKEX:8496
|
SG |
|
Garware Technical Fibres Ltd
NSE:GARFIBRES
|
IN |
|
Zhejiang Zhaolong Interconnect Technology Co Ltd
SZSE:300913
|
CN |
|
Jiangsu Leili Motor Co Ltd
SZSE:300660
|
CN |
|
Narendra Properties Ltd
BSE:531416
|
IN |
|
Askul Corp
TSE:2678
|
JP |
|
C
|
Cambi ASA
OSE:CAMBI
|
NO |
|
C
|
Changzhou Xiangming Intelligent Drive System Corporation
SZSE:301226
|
CN |
|
C
|
Central Holding Group Co Ltd
HKEX:1735
|
HK |
|
Rithwik Facility Management Services Ltd
BSE:540843
|
IN |
|
G
|
Gansu Qilianshan Cement Group Co Ltd
SSE:600720
|
CN |
|
Paramount Bed Holdings Co Ltd
TSE:7817
|
JP |
|
H
|
Handal Energy Bhd
KLSE:HANDAL
|
MY |
|
Fitipower Integrated Technology Inc
TWSE:4961
|
TW |
|
Aeon Credit Service Asia Co Ltd
HKEX:900
|
HK |
|
Themis Medicare Ltd
NSE:THEMISMED
|
IN |
|
Fukushima Galilei Co Ltd
TSE:6420
|
JP |
Oncosil Medical Ltd
Research & Development
Oncosil Medical Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Oncosil Medical Ltd
ASX:OSL
|
Research & Development
-AU$5.2m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Oncosil Medical Ltd
Glance View
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2005-08-15. The firm is focused on unresectable locally advanced pancreatic cancer (LAPC). The firm's lead product, OncoSil, is a single-use brachytherapy internal radiation device used to deliver a pre-determined dose of beta radiation directly into cancerous tissue. The OncoSil consists of microparticles that contain a radioisotope phosphorous-32 and a formulated diluent, which acts as a carrier to facilitate the implantation of the microparticles into the target tissue. The company enables doctors to target a greater radiation dose directly to the tumor, while sparing surrounding critical organs. The OncoSil device is used for the treatment of unresectable LAPC and is used in conjunction with chemotherapy.
See Also
What is Oncosil Medical Ltd's Research & Development?
Research & Development
-5.2m
AUD
Based on the financial report for Dec 31, 2025, Oncosil Medical Ltd's Research & Development amounts to -5.2m AUD.
What is Oncosil Medical Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-9%
Over the last year, the Research & Development growth was -87%. The average annual Research & Development growth rates for Oncosil Medical Ltd have been -24% over the past three years , -9% over the past five years , and -9% over the past ten years .
